Brachiobasilic arteriovenous fistula for hemodialysis access : experience at King Hussein Medical center

Abstract EN

Objective: To evaluate the (one, two, three) year primary and secondary patency of brachiobasilic arteriovenous fistula (BBAVF) as hemodialysis vascular access and procedure complications at King Hussein Medical Center.

Methods: A retrospective single-center study, analyzing the patency of 129 BBAVF procedures for hemodialysis vascular access and associated complications.

Follow up patency was assessed by adequacy of BBAVF for hemodialysis over 3 years' period.

Results: (One, two, three) year primary patency was (75, 62, 47) % respectively and (one, two, three) year secondary patency was (77, 64, 50) % respectively.

Failure of maturation was seen in 16 patients (12%).

Hematoma developed in 5 patients (3.9%).

Bleeding related to infection developed in 3 patients (2.3%).

Wound infection developed in 13 patients (10.1%).

Arterial steal developed in 14 patients (10.9%).

Venous hypertension developed in 12 patients (9.3%).

Ischemic monomelic neuropathy developed in 2 patients (1.6%).

Pseudoaneurysm at puncture sites developed in 12 patients (9.3%).

Thrombosis developed in 24 patients (19%).

There was no procedure related mortality.

Conclusion: BBAVF is an important and effective option in KHMC for chronic renal failure patients requiring hemodialysis with acceptable patency and complication rates.